Dr. Vakkalagadda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3485 S Bond Ave
Building 2
Portland, OR 97239- Is this information wrong?
Education & Training
- McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2020 - 2023
- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2017 - 2020
- Washington University in St. Louis School of MedicineClass of 2017, MD
- Washington University in St. LouisBA, Chemistry (Biochemistry), Cum Laude, 2009 - 2013
Certifications & Licensure
- OR State Medical License 2023 - 2025
- WA State Medical License 2023 - 2024
- IL State Medical License 2017 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Addition of Trastuzumab Deruxtecan to Selpercatinib in a Patient With RET Fusion-Driven NSCLC and an Acquired HER2 Amplification: Case Report.Vakkalagadda, C., Patel, J.> ;JTO Clinical and Research Reports. 2023 Dec 1
- 7 citationsNovel Therapies and Approaches to Relapsed/Refractory HL Beyond ChemotherapyAlain Mina, Chetan Vakkalagadda, Barbara Pro> ;Cancers. 2019 Mar 25
- Cytomegalovirus-Associated Hemophagocytic Syndrome in a 59-Year-Old Woman with Ulcerative Colitis.Vakkalagadda CV, Cadena-Semanate R, Non LR> ;Am J Med. 2017 Jul
Books/Book Chapters
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: